Share Price and Basic Stock Data
Last Updated: November 20, 2025, 10:41 pm
| PEG Ratio | 1.45 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Healthy Life Agritec Ltd operates in the Milk & Milk Products industry, showcasing a notable growth trajectory in its revenue streams. The company reported sales of ₹34 Cr in March 2022, which rose to ₹108 Cr by March 2023, marking a year-over-year increase of 217.6%. This upward momentum continued, with sales reaching ₹133 Cr in March 2024 and projected to hit ₹172 Cr by March 2025. The quarterly sales data indicates a significant spike, particularly in September 2022, when sales peaked at ₹68 Cr. However, sales remained stagnant at ₹40 Cr in both September 2023 and March 2024, suggesting potential challenges in sustaining growth momentum. The overall growth reflects Healthy Life Agritec’s ability to capitalize on market opportunities, though the fluctuations in quarterly performance highlight the need for strategic adjustments to maintain a consistent upward trend.
Profitability and Efficiency Metrics
Healthy Life Agritec Ltd’s profitability metrics present a mixed picture. The company’s operating profit margin (OPM) stood at 4% as of the latest reporting, though it has varied over the past few quarters, with a peak of 4% in March 2022 and a low of 2% in September 2023. The net profit for March 2023 was recorded at ₹2 Cr, rising to ₹3 Cr by March 2024, indicating a modest improvement in profitability. The return on equity (ROE) is reported at 10.6%, while the return on capital employed (ROCE) stands at 13.3%, both of which are relatively competitive within the sector. However, the cash conversion cycle (CCC) has lengthened significantly to 69 days, highlighting inefficiencies in inventory management and receivables collection, which may constrain cash flow and operational agility.
Balance Sheet Strength and Financial Ratios
The balance sheet of Healthy Life Agritec Ltd reflects a prudent financial management strategy, with no reported borrowings, which enhances its financial stability. The company’s market capitalization is ₹72.4 Cr, with a price-to-earnings (P/E) ratio of 19.5, suggesting a moderate valuation relative to its earnings potential. The interest coverage ratio (ICR) is a robust 12.96x, indicating that the company can comfortably cover its interest obligations, despite having no interest-bearing debt. The price-to-book value (P/BV) ratio is reported at 4.32x, which is on the higher side, signaling that the market may be pricing in future growth potential. Overall, Healthy Life Agritec exhibits a solid financial foundation, but the high P/BV ratio might raise concerns about overvaluation, especially in the context of its fluctuating profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Healthy Life Agritec Ltd shows a significant shift in promoter ownership, which has decreased from 54.57% in September 2022 to 28.86% by November 2025. This decline may raise concerns among investors regarding the commitment of the founding members. Conversely, public ownership has increased from 45.43% in September 2022 to 70.72% in November 2025, indicating growing investor interest from retail participants. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold minimal stakes at 0.40% and 0.03%, respectively, which could suggest a lack of institutional confidence. The number of shareholders has also fluctuated, with a notable increase to 881 by November 2025, which may reflect a positive sentiment among retail investors despite the declining promoter stake.
Outlook, Risks, and Final Insight
Looking ahead, Healthy Life Agritec Ltd has the potential to enhance its market position, driven by its improving sales trajectory and profitability metrics. However, significant risks remain, particularly the elongated cash conversion cycle and the declining promoter stake, which could affect investor confidence. The company’s ability to streamline its operations and maintain profitability will be crucial in navigating these challenges. Additionally, the increasing public ownership may lead to greater volatility in stock performance as retail investors react to market changes. If Healthy Life Agritec can address its operational inefficiencies and sustain growth, it may solidify its foothold in the competitive Milk & Milk Products sector. Conversely, failure to manage these risks could hinder its growth trajectory and market valuation.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Healthy Life Agritec Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Dairies Ltd | 108 Cr. | 42.3 | 74.0/38.2 | 4.68 | 17.0 | 0.00 % | % | % | 10.0 |
| Healthy Life Agritec Ltd | 71.7 Cr. | 14.4 | 61.2/13.8 | 19.3 | 7.25 | 0.00 % | 13.3 % | 10.6 % | 10.0 |
| Dodla Dairy Ltd | 7,298 Cr. | 1,211 | 1,525/962 | 28.1 | 254 | 0.41 % | 26.6 % | 19.8 % | 10.0 |
| Vadilal Industries Ltd | 3,860 Cr. | 5,368 | 7,399/3,411 | 28.7 | 1,092 | 0.39 % | 25.1 % | 24.0 % | 10.0 |
| Umang Dairies Ltd | 189 Cr. | 85.7 | 128/67.0 | 309 | 20.7 | 0.00 % | 4.52 % | 1.35 % | 5.00 |
| Industry Average | 6,576.83 Cr | 1,179.06 | 68.73 | 226.64 | 0.27% | 17.99% | 15.49% | 7.29 |
Quarterly Result
| Metric | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 12 | 22 | 68 | 40 | 40 | 93 | 88 | 84 |
| Expenses | 12 | 21 | 67 | 38 | 40 | 90 | 86 | 81 |
| Operating Profit | 0 | 1 | 1 | 1 | 1 | 3 | 2 | 3 |
| OPM % | 2% | 4% | 2% | 3% | 2% | 3% | 2% | 4% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 1 | 1 | 1 | 1 | 3 | 2 | 3 |
| Tax % | 26% | 26% | 26% | 28% | 26% | 25% | 25% | 25% |
| Net Profit | 0 | 1 | 1 | 1 | 0 | 2 | 1 | 2 |
| EPS in Rs | 130.00 | 0.68 | 0.30 | 0.38 | 0.20 | 0.94 | 0.47 | 0.84 |
Last Updated: May 31, 2025, 5:43 am
Below is a detailed analysis of the quarterly data for Healthy Life Agritec Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 84.00 Cr.. The value appears to be declining and may need further review. It has decreased from 88.00 Cr. (Sep 2024) to 84.00 Cr., marking a decrease of 4.00 Cr..
- For Expenses, as of Mar 2025, the value is 81.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 86.00 Cr. (Sep 2024) to 81.00 Cr., marking a decrease of 5.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
- For OPM %, as of Mar 2025, the value is 4.00%. The value appears strong and on an upward trend. It has increased from 2.00% (Sep 2024) to 4.00%, marking an increase of 2.00%.
- For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Tax %, as of Mar 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 25.00%.
- For Net Profit, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.84. The value appears strong and on an upward trend. It has increased from 0.47 (Sep 2024) to 0.84, marking an increase of 0.37.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:09 am
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Sales | 34 | 108 | 133 | 172 |
| Expenses | 33 | 106 | 129 | 167 |
| Operating Profit | 1 | 2 | 4 | 5 |
| OPM % | 4% | 2% | 3% | 3% |
| Other Income | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 2 | 3 | 4 |
| Tax % | 26% | 28% | 25% | 25% |
| Net Profit | 1 | 2 | 3 | 3 |
| EPS in Rs | 0.40 | 0.34 | 0.57 | 0.66 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 50.00% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -50.00% | -50.00% |
Healthy Life Agritec Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 3 years from 2022-2023 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 72% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 59% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 77% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 10% |
| Last Year: | 11% |
Last Updated: September 5, 2025, 3:41 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Debtor Days | 30 | 31 | 68 | 67 |
| Inventory Days | 7 | 9 | 13 | 18 |
| Days Payable | 14 | 1 | 8 | 16 |
| Cash Conversion Cycle | 23 | 39 | 73 | 69 |
| Working Capital Days | 88 | 75 | 69 | 62 |
| ROCE % | 12% | 13% | 13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.31 | 1.14 | 0.81 | 0.81 |
| Diluted EPS (Rs.) | 1.35 | 1.14 | 0.81 | 0.81 |
| Cash EPS (Rs.) | 1.38 | 1.21 | 0.74 | 0.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 13.85 | 12.23 | 11.09 | 10.89 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 13.85 | 12.23 | 11.09 | 10.89 |
| Revenue From Operations / Share (Rs.) | 69.27 | 60.40 | 48.98 | 33.93 |
| PBDIT / Share (Rs.) | 1.97 | 1.64 | 1.05 | 1.18 |
| PBIT / Share (Rs.) | 1.91 | 1.57 | 0.99 | 1.14 |
| PBT / Share (Rs.) | 1.75 | 1.52 | 0.94 | 1.12 |
| Net Profit / Share (Rs.) | 1.31 | 1.14 | 0.68 | 0.82 |
| NP After MI And SOA / Share (Rs.) | 1.31 | 1.14 | 0.68 | 0.81 |
| PBDIT Margin (%) | 2.84 | 2.71 | 2.14 | 3.47 |
| PBIT Margin (%) | 2.75 | 2.60 | 2.02 | 3.34 |
| PBT Margin (%) | 2.53 | 2.51 | 1.92 | 3.29 |
| Net Profit Margin (%) | 1.89 | 1.88 | 1.40 | 2.43 |
| NP After MI And SOA Margin (%) | 1.89 | 1.88 | 1.40 | 2.39 |
| Return on Networth / Equity (%) | 9.47 | 9.31 | 6.19 | 7.48 |
| Return on Capital Employeed (%) | 13.07 | 12.13 | 8.80 | 10.40 |
| Return On Assets (%) | 6.22 | 7.44 | 5.53 | 5.49 |
| Long Term Debt / Equity (X) | 0.05 | 0.05 | 0.01 | 0.00 |
| Total Debt / Equity (X) | 0.21 | 0.09 | 0.05 | 0.07 |
| Asset Turnover Ratio (%) | 4.00 | 4.36 | 5.12 | 0.00 |
| Current Ratio (X) | 2.84 | 6.20 | 10.05 | 3.39 |
| Quick Ratio (X) | 2.33 | 5.34 | 9.06 | 3.24 |
| Interest Coverage Ratio (X) | 12.96 | 30.72 | 20.82 | 65.48 |
| Interest Coverage Ratio (Post Tax) (X) | 9.63 | 22.31 | 14.59 | 46.99 |
| Enterprise Value (Cr.) | 155.60 | 10.53 | 14.49 | 0.00 |
| EV / Net Operating Revenue (X) | 0.90 | 0.07 | 0.13 | 0.00 |
| EV / EBITDA (X) | 31.84 | 2.91 | 6.26 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.86 | 0.06 | 0.12 | 0.00 |
| Price / BV (X) | 4.32 | 0.31 | 0.55 | 0.00 |
| Price / Net Operating Revenue (X) | 0.86 | 0.06 | 0.12 | 0.00 |
| EarningsYield | 0.02 | 0.29 | 0.11 | 0.00 |
After reviewing the key financial ratios for Healthy Life Agritec Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 5. It has increased from 1.14 (Mar 24) to 1.31, marking an increase of 0.17.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 5. It has increased from 1.14 (Mar 24) to 1.35, marking an increase of 0.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 3. It has increased from 1.21 (Mar 24) to 1.38, marking an increase of 0.17.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 13.85. It has increased from 12.23 (Mar 24) to 13.85, marking an increase of 1.62.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 13.85. It has increased from 12.23 (Mar 24) to 13.85, marking an increase of 1.62.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 69.27. It has increased from 60.40 (Mar 24) to 69.27, marking an increase of 8.87.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.97. This value is below the healthy minimum of 2. It has increased from 1.64 (Mar 24) to 1.97, marking an increase of 0.33.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.91. This value is within the healthy range. It has increased from 1.57 (Mar 24) to 1.91, marking an increase of 0.34.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.75. This value is within the healthy range. It has increased from 1.52 (Mar 24) to 1.75, marking an increase of 0.23.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 2. It has increased from 1.14 (Mar 24) to 1.31, marking an increase of 0.17.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 2. It has increased from 1.14 (Mar 24) to 1.31, marking an increase of 0.17.
- For PBDIT Margin (%), as of Mar 25, the value is 2.84. This value is below the healthy minimum of 10. It has increased from 2.71 (Mar 24) to 2.84, marking an increase of 0.13.
- For PBIT Margin (%), as of Mar 25, the value is 2.75. This value is below the healthy minimum of 10. It has increased from 2.60 (Mar 24) to 2.75, marking an increase of 0.15.
- For PBT Margin (%), as of Mar 25, the value is 2.53. This value is below the healthy minimum of 10. It has increased from 2.51 (Mar 24) to 2.53, marking an increase of 0.02.
- For Net Profit Margin (%), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 5. It has increased from 1.88 (Mar 24) to 1.89, marking an increase of 0.01.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 8. It has increased from 1.88 (Mar 24) to 1.89, marking an increase of 0.01.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.47. This value is below the healthy minimum of 15. It has increased from 9.31 (Mar 24) to 9.47, marking an increase of 0.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is 13.07. This value is within the healthy range. It has increased from 12.13 (Mar 24) to 13.07, marking an increase of 0.94.
- For Return On Assets (%), as of Mar 25, the value is 6.22. This value is within the healthy range. It has decreased from 7.44 (Mar 24) to 6.22, marking a decrease of 1.22.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has increased from 0.09 (Mar 24) to 0.21, marking an increase of 0.12.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 4.00. It has decreased from 4.36 (Mar 24) to 4.00, marking a decrease of 0.36.
- For Current Ratio (X), as of Mar 25, the value is 2.84. This value is within the healthy range. It has decreased from 6.20 (Mar 24) to 2.84, marking a decrease of 3.36.
- For Quick Ratio (X), as of Mar 25, the value is 2.33. This value exceeds the healthy maximum of 2. It has decreased from 5.34 (Mar 24) to 2.33, marking a decrease of 3.01.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 12.96. This value is within the healthy range. It has decreased from 30.72 (Mar 24) to 12.96, marking a decrease of 17.76.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.63. This value is within the healthy range. It has decreased from 22.31 (Mar 24) to 9.63, marking a decrease of 12.68.
- For Enterprise Value (Cr.), as of Mar 25, the value is 155.60. It has increased from 10.53 (Mar 24) to 155.60, marking an increase of 145.07.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has increased from 0.07 (Mar 24) to 0.90, marking an increase of 0.83.
- For EV / EBITDA (X), as of Mar 25, the value is 31.84. This value exceeds the healthy maximum of 15. It has increased from 2.91 (Mar 24) to 31.84, marking an increase of 28.93.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.06 (Mar 24) to 0.86, marking an increase of 0.80.
- For Price / BV (X), as of Mar 25, the value is 4.32. This value exceeds the healthy maximum of 3. It has increased from 0.31 (Mar 24) to 4.32, marking an increase of 4.01.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.06 (Mar 24) to 0.86, marking an increase of 0.80.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.29 (Mar 24) to 0.02, marking a decrease of 0.27.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Healthy Life Agritec Ltd:
- Net Profit Margin: 1.89%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 13.07% (Industry Average ROCE: 17.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.47% (Industry Average ROE: 15.49%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.63
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 19.3 (Industry average Stock P/E: 68.73)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.21
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.89%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Milk & Milk Products | SH-B/09, New Heera Panna CHS LTD, Gokul Village Shanti Park, Mira Road East, Thane Maharashtra 401107 | cs@healthylifeagritec.com http://www.healthylifeagritec.com |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Divya Mojjada | Managing Director |
| Mr. Anil Kumar Vijay | Independent Director |
| Mr. Mohammed Sadiq | Non Independent Director |
| Mr. Apra Sharma | Independent Director |